Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
29.93
+0.44 (1.49%)
May 26, 2026, 4:00 PM EDT - Market closed
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $1.77 billion as of May 26, 2026. Its market cap has increased by 81.91% in one year.
Market Cap
1.77B
Enterprise Value
1.50B
1-Year Change
81.91%
Ranking
Category
Stock Price
$29.93
Market Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $1.77B, an increase of 1,013.34%. That is a compound annual growth rate of 61.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.74B | 51.15% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.81B |
| Rapport Therapeutics | 1.80B |
| Ocular Therapeutix | 1.80B |
| Sarepta Therapeutics | 1.77B |
| Vericel | 1.77B |
| Syndax Pharmaceuticals | 1.77B |
| Intellia Therapeutics | 1.76B |
| Harmony Biosciences Holdings | 1.75B |